1. Home
  2. GTEC vs MRKR Comparison

GTEC vs MRKR Comparison

Compare GTEC & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

HOLD

Current Price

$1.05

Market Cap

17.7M

Sector

Industrials

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.45

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTEC
MRKR
Founded
2006
N/A
Country
United States
United States
Employees
345
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
16.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTEC
MRKR
Price
$1.05
$1.45
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.17
AVG Volume (30 Days)
192.8K
330.4K
Earning Date
11-07-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$86,168,664.00
$4,694,988.00
Revenue This Year
$5.64
N/A
Revenue Next Year
$3.93
N/A
P/E Ratio
$1.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.81
52 Week High
$2.92
$5.95

Technical Indicators

Market Signals
Indicator
GTEC
MRKR
Relative Strength Index (RSI) 46.23 67.32
Support Level $0.99 $1.40
Resistance Level $1.17 $1.49
Average True Range (ATR) 0.07 0.10
MACD 0.01 0.03
Stochastic Oscillator 52.00 95.45

Price Performance

Historical Comparison
GTEC
MRKR

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: